🇺🇸 FDA
Pipeline program

L-Glutamine

1R01FD003531-01

Phase 2 small_molecule completed

Quick answer

L-Glutamine for Pulmonary Hypertension is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Pulmonary Hypertension
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials